Italy
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -423.03 M
|
Dec. 31, 2023 | USD 61.85 | 0.84% |
|
Italy |
|
2 |
USD -226.22 M
|
Dec. 31, 2023 | USD 41.35 | 1.53% |
|
Italy |
|
3 |
USD -50.18 M
|
Dec. 31, 2023 | USD 107.00 | 0.25% |
|
Italy |
|
4 |
USD -6.12 M
|
Dec. 31, 2023 | USD 19.14 | -0.29% |
|
Italy |
|
5 |
USD -490.26 K
|
Dec. 31, 2023 | USD 7.70 | 1.62% |
|
Italy |
|
6 |
USD -91.29 K
|
Dec. 31, 2023 | USD 1.99 | -0.79% |
|
Italy |
|
7 |
USD -15.22 K
|
Dec. 31, 2023 | USD 3.52 | -12.00% |
|
Italy |
|
8 |
USD -12.14 K
|
Dec. 31, 2023 | USD 10.86 | 4.76% |
|
Italy |
The Biotechnology company in Italy with the highest Capital Expenditure is Recordati Industria Chimica e Farmaceutica S.p.A. (Milan Stock Exchange: REC.MI) at USD -423.03 M.
The Biotechnology company in Italy with the lowest Capital Expenditure is Newron Pharmaceuticals S.p.A. (XETRA: NP5.DE) at USD -12.14 K.
The top 10 Biotechnology companies in Italy by Capital Expenditure are Recordati Industria Chimica e Farmaceutica S.p.A., SOL S.p.A., DiaSorin S.p.A., Philogen S.p.A., Franchetti S.p.A., Arterra Bioscience, Genenta Science S.p.A. and Newron Pharmaceuticals S.p.A..
The bottom 10 Biotechnology companies in Italy by Capital Expenditure are Newron Pharmaceuticals S.p.A., Genenta Science S.p.A., Arterra Bioscience, Franchetti S.p.A., Philogen S.p.A., DiaSorin S.p.A., SOL S.p.A. and Recordati Industria Chimica e Farmaceutica S.p.A..